On November 20^th, 2012, Shanghai Cardiac Function Test Conference, organized by Angy (China) Medical Limited, was successfully held in Shanghai Jin Mao Tower. Angy's CEO and some famous experts, including Professor Yan Li from Shanghai Ruijin Hospital，Professor Alberto Avolio, a well-known cardiovascular expert from Austrian Macquarie University, Director Ming Fan from Shanghai Changzheng Hospital, Director Dadong Zhang from Minhang Central Hospital, attended this grand conference.
      

This grand conference mainly focused on the core advantages of AtCor SphygmoCor Cardiovascular Management System and its importance in cardiovascular clinical diagnosis and treatment. SphygmoCor is the only cardiovascular management device in China that was integrated with 4 superior functions, including measurement of central blood pressure, arterial stiffness, HRV and AIx. The Aix (Augmentation Index), provided by this device only, is the indicator of aorta distensibility and cardiac workload and it has been proved to be an independent predictor of cardiovascular mortality. The domestic and overseas experts, invited as the speakers, gave comprehensive presentations on the outstanding technical parameters of SphygmoCor Cardiovascular Management System as well as its clinical application in domestic and overseas hospitals. The experts and directors present at the conference gained a deeper understanding on non-invasive measurement of central blood pressure and arterial stiffness, who also exchanged their ideas at the conference. They all agreed that SphygmoCor Cardiovascular Management System is a quicker and more professional tool for detecting cardiovascular function in both clinical and research environment. Its significance is profoundly manifested in predicting cardiovascular disease risk in large population and assessing the effect of anti-hypertension drugs.
      

Angy took this event as an opportunity to learn the core advantages and clinical application of SphygmoCor Cardiovascular Management System from domestic and overseas experts, hoping that Angy can bring in high-tech approaches and ways to detect cardiovascular disease in China.